Does DOFETILIDE Cause Therapeutic product effect delayed? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic product effect delayed have been filed in association with DOFETILIDE (Dofetilide). This represents 0.1% of all adverse event reports for DOFETILIDE.
5
Reports of Therapeutic product effect delayed with DOFETILIDE
0.1%
of all DOFETILIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From DOFETILIDE?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOFETILIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DOFETILIDE Cause?
Drug ineffective (654)
Atrial fibrillation (438)
Death (285)
Electrocardiogram qt prolonged (267)
Dyspnoea (230)
Dizziness (228)
Fatigue (180)
Malaise (175)
Headache (154)
Palpitations (128)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
Which DOFETILIDE Alternatives Have Lower Therapeutic product effect delayed Risk?
DOFETILIDE vs DOLUTEGRAVIR
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE
DOFETILIDE vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOFETILIDE vs DOLUTEGRAVIR\RILPIVIRINE
DOFETILIDE vs DOMPERIDONE